Relationship Between Spravato and Ketamine
Spravato is derived from ketamine, but it is not identical to the ketamine that has been used for decades in anesthesia or off-label mental health treatment. Ketamine is a compound made up of two mirror-image molecules called enantiomers. Spravato contains only one of those forms, known as esketamine.
By isolating esketamine, Spravato provides a more targeted version of ketamine’s antidepressant effects. This distinction plays an important role in how the medication is regulated, administered, and monitored.
FDA Approval and Regulation Differences
One of the most important differences between Spravato and ketamine is regulatory approval. Spravato is FDA approved for treatment-resistant depression and depressive symptoms in adults with major depressive disorder when used alongside an oral antidepressant.
Ketamine itself does not have FDA approval specifically for depression, although it may be used off-label in some clinical settings. Spravato’s approval means it has undergone extensive clinical trials demonstrating safety, effectiveness, and standardized dosing protocols.
Method of Administration
Spravato is administered as a nasal spray in a clinical setting. Patients self-administer the medication under supervision and remain monitored afterward for safety and tolerability. This structured process helps ensure consistent dosing and controlled delivery.
Ketamine, when used for mental health treatment, is most commonly administered intravenously, though other forms exist. IV ketamine requires different equipment, dosing calculations, and monitoring protocols.
Differences in Treatment Experience
The patient experience can differ between Spravato and ketamine treatments. Spravato sessions are scheduled according to an FDA-recommended treatment plan, particularly during the initial phase. Patients remain under observation after each session to monitor blood pressure, alertness, and overall comfort.
Ketamine treatments vary widely depending on the provider and protocol. Because ketamine is not FDA approved for depression, treatment approaches may differ from clinic to clinic.
Spravato’s standardized structure offers consistency and predictability for patients receiving care.
Safety and Monitoring Standards
Spravato is available only through a Risk Evaluation and Mitigation Strategy program, which requires certified providers and clinics. This program ensures that patients are carefully screened, monitored, and educated before and after each treatment.
Ketamine clinics may also prioritize safety, but there is no unified federal program governing its use for depression. Spravato’s REMS requirements help maintain a high level of oversight and patient protection.
At Revival Psych, safety protocols are strictly followed to support patient well-being throughout treatment.
Mechanism of Action in the Brain
Both Spravato and ketamine affect the brain’s glutamate system, which plays a key role in mood regulation and neural communication. By influencing glutamate signaling, these treatments promote changes in neural connectivity and plasticity.
This mechanism differs from traditional antidepressants that primarily target serotonin or norepinephrine. The glutamate-based approach is one reason Spravato may benefit patients who have not responded to standard medications.
Although the underlying mechanism is similar, the formulation and delivery of Spravato distinguish it from ketamine.
Choosing the Right Option
Deciding between Spravato and ketamine-based treatments depends on several factors, including diagnosis, medical history, response to previous treatments, and personal preferences. Some patients value the FDA approval and structured oversight that Spravato provides.
A comprehensive evaluation helps determine which approach aligns best with a patient’s needs and goals. At Revival Psych, treatment decisions are guided by evidence, safety, and individualized care.
Conclusion
Spravato and ketamine are closely related, but they are not the same. Spravato contains esketamine, a specific form of ketamine that has been FDA approved for certain depressive conditions and is administered under strict clinical supervision. Ketamine, while similar in action, differs in formulation, regulation, and delivery.
At Revival Psych, Spravato is offered as part of a carefully monitored treatment plan designed to support patients with treatment-resistant depression. Understanding the differences between Spravato and ketamine helps patients feel confident as they explore advanced mental health care options.
About the Author
Erin Jones
